Back

Serially measured blood biomarkers collected in the context of usual care predict clinical outcome in a real-world heart failure population

20 May 2025 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Frailty and biomarkers in heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Mr Thomas Frederik Kok

Erasmus University Rotterdam, Rotterdam (Netherlands (The))

4 More presentations in this session

Presentation thumbnail
Comparative characteristics of patients with cardiac amyloidosis with and without monoclonal gammopathy in the TTRACK study population
Professor R. Jurcut (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Survival analysis of nonagenarian patients in a specific heart failure unit
Mrs S. Gonzalez Sosa (Palmas de Gran Canaria, Las, ES)
Abstract Slides Video
Presentation thumbnail
Characteristics of heart failure patients treated in primary care - a 20-year perspective of real-world data.
Doctor A. Drohomirecka (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Association of charlson comorbidity index with clinical characteristics and outcomes in heart failure across the EF spectrum
Doctor N. Farooqui (Rochester, US)
Abstract Slides Video

Access the full session

Session thumbnail
Frailty and biomarkers in heart failure

The Event

Event poster

Heart Failure 2025

20 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Blood cell counts as a source of evidence for prognostic information in patients with acute heart failure: findings from a large, single-centre study
thumbnail
Congress Presentation
The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure
thumbnail
Congress Presentation
Has the role of biomarkers for early heart failure detection changed In the digital era?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources